609 Deputy Michelle Mulherin asked the Minister for Health following the decision by the National Council for Pharma Economics on 22 September 2011 to approve the drug Fingolimod, Gilenya as a cost-effective therapy for the treatment of relapsing-remitting multiple sclerosis patients in the Irish healthcare setting, when this drug will be made available to all patients who need it; and if he will make a statement on the matter. [29211/12]

Summary

609 Deputy Michelle Mulherin asked the Minister for Health following the decision by the National Council for Pharma Economics on 22 September 2011 to approve the drug Fingolimod, Gilenya as a cost-effective therapy for the treatment of relapsing-remitting multiple sclerosis patients in the Irish healthcare setting, when this drug will be made available to all patients who need it; and if he will make a statement on the matter. [29211/12]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 19 June 2012

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.